SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-24-000253
Filing Date
2024-04-10
Accepted
2024-04-10 17:05:42
Documents
1
Period of Report
2024-04-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3798
  Complete submission text file 0000904454-24-000253.txt   6271
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42001 | Film No.: 24836520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901
Business Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901 (732) 524-3218
Johnson & Johnson Innovation - JJDC, Inc. (Reporting) CIK: 0000924020 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-42001 | Film No.: 24836519

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Issuer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)